- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
- AbCellera Announces Resignation of Board Member
- AbCellera to Present at Upcoming Investor Conferences in March
- AbCellera Reports Full Year 2023 Business Results
- AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
More ▼
Key statistics
On Thursday, Abcellera Biologics Inc (ABCL:NSQ) closed at 4.53, 17.05% above the 52 week low of 3.87 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.51 |
---|---|
High | 4.65 |
Low | 4.49 |
Bid | 4.53 |
Offer | 4.61 |
Previous close | 4.49 |
Average volume | 955.32k |
---|---|
Shares outstanding | 292.78m |
Free float | 208.41m |
P/E (TTM) | -- |
Market cap | 1.33bn USD |
EPS (TTM) | -0.5062 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼